TREA

87603889 - KOBIOLABS

Follow

Information

  • Trademark
  • 87603889
  • Serial Number
    87603889
  • Registration Number
    5791315
  • Filing Date
    September 11, 2017
    6 years ago
  • Registration Date
    July 02, 2019
    4 years ago
  • Transaction Date
    July 02, 2019
    4 years ago
  • Status Date
    July 02, 2019
    4 years ago
  • Published for Opposition Date
    April 16, 2019
    5 years ago
  • Location Date
    July 02, 2019
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    GULIANO, ROBERT N
  • Attorney Docket Number
    28035.2036
    Attorney Name
    Diane J. Mason
    Law Office Assigned Location Code
    L50
  • Owners
Information
Mark Drawing Code
3000
Mark Identification
KOBIOLABS
Case File Statements
  • CC0000: The colors white, gray, green and yellow-green are claimed as a feature of the mark.
  • DM0000: The mark consists of the word "KOBIOLABS" in block lettering with the "KO" in the color yellow-green and the "BIOLABS" in the color gray. To the left of the word "KOBIOLABS" is a circular design shaded gray on the interior edges of the circle and transitioning to white towards the circle's interior. A green leaf is positioned in the center of the circle. The rest of the white represents background and is not part of the mark. All other white and gray in the mark represents background and shading areas and is not part of the mark.
  • GS0051: Pharmaceutical and veterinary preparations, namely, preparations for the prevention of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease; Microorganism preparations, namely, nutritive substances for microorganisms for medical or veterinary purposes; Microorganism preparations, namely, microorganism cells for medical or veterinary purposes; Cultures of microorganisms for medical purposes; Biological preparations for medical or veterinary purposes, namely, preparations for the treatment of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease; Dietetic food supplements; Dietetic foods adapted for medical purposes; Nutraceuticals for medical purposes, namely, for the treatment of inflammatory bowel disease, irritable bowel syndrome, constipation, diarrhea, metabolic syndrome, obesity, diabetes, hypertension, insulin resistance, high blood cholesterol, high blood Triglycerides, cardiovascular disease, autoimmune disease, atopic dermatitis, arthritis, asthma, allergy, Crohn's disease, mental diseases, neurodegenerative disease, cancer, infectious disease, liver disease and inflammatory disease
  • GS0421: Consultation in the field of health risk assessment, namely, predicting health risks of individuals with regard to medical disease; Drug discovery services; Provision of scientific information and advice in the field of microorganisms; DNA testing for scientific research purposes; DNA analysis for scientific research purposes; DNA sequencing analysis for scientific research purposes; consultation and providing information in the fields of biomedicine for scientific and research purposes; Consultancy in analysis of biology sequence processing for medical research purposes; Consultancy in analysis of genomics for medical research purposes; scientific research in the fields of medicine, health and pharmacology; Consultation and providing information in the fields of and pharmacology
  • GS0441: Performing diagnosis of diseases; Provision of genetic testing for medical treatment purposes; Provision of gene therapy for medical treatment purposes; DNA screening for medical purposes; Consultation and providing information in the fields of medicine and health
Case File Event Statements
  • 7/2/2019 - 4 years ago
    30 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/10/2019 - 5 years ago
    29 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/16/2019 - 5 years ago
    28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/16/2019 - 5 years ago
    27 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/27/2019 - 5 years ago
    26 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/28/2019 - 5 years ago
    25 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/26/2019 - 5 years ago
    24 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 2/25/2019 - 5 years ago
    23 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/25/2019 - 5 years ago
    22 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/5/2018 - 5 years ago
    21 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/5/2018 - 5 years ago
    20 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/5/2018 - 5 years ago
    19 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/19/2018 - 6 years ago
    18 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 6/19/2018 - 6 years ago
    17 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 6/19/2018 - 6 years ago
    16 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 6/19/2018 - 6 years ago
    15 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 6/9/2018 - 6 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/8/2018 - 6 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/8/2018 - 6 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 12/21/2017 - 6 years ago
    11 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 12/21/2017 - 6 years ago
    10 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 12/21/2017 - 6 years ago
    9 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 12/18/2017 - 6 years ago
    8 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 12/18/2017 - 6 years ago
    7 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 12/18/2017 - 6 years ago
    6 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 12/18/2017 - 6 years ago
    5 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 12/14/2017 - 6 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/16/2017 - 6 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 9/15/2017 - 6 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 9/14/2017 - 6 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP